Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital Hepatic Fibrosis and/or Autosomal Recessive Polycystic Kidney Disease: A Single-center Experience. | Pediatr Gastroenterol Hepatol Nutr | 2026 | 41567255 | PubTator, text mining | PubMed |
| miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation. | Inflammation | 2026 | 41549135 | PubTator, text mining | PubMed |
| Integrating next-generation sequencing with biochemical screening to optimize first-tier newborn screening systems. | Hum Genomics | 2026 | 41547924 | PubTator, text mining | PubMed |
| Elucidating the mechanism of polycyclic aromatic hydrocarbons-induced osteoporosis through network toxicology and molecular docking approaches: BaP as a model compound. | Ecotoxicol Environ Saf | 2026 | 41547189 | PubTator, text mining | PubMed |
| Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth. | Cell Commun Signal | 2026 | 41546097 | PubTator, text mining | PubMed |
| Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability to Cause Aortopathy. | JACC Basic Transl Sci | 2026 | 41544301 | PubTator, text mining | PubMed |
| Exome-Wide Analysis Identifies a Rare EXD3 Missense Variant Associated With Diabetic Kidney Disease. | Kidney Int Rep | 2026 | 41541775 | PubTator, text mining | PubMed |
| Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells. | Kidney360 | 2026 | 41499173 | PubTator, text mining | PubMed |
| Whole-genome sequencing identified a deep intronic COL4A5 variant causing aberrant splicing in a female patient with X-linked Alport syndrome. | CEN Case Rep | 2026 | 41483114 | PubTator, text mining | PubMed |
| Exome Sequencing in a Large Cohort with Ciliopathy-Related Kidney Disease. | Clin J Am Soc Nephrol | 2026 | 41343253 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and cyclosporine-responsive proteinuria in nail-patella syndrome with a novel LMX1B mutation. | Pediatr Nephrol | 2026 | 41249554 | PubTator, text mining | PubMed |
| From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome. | Pediatr Nephrol | 2026 | 41243004 | PubTator, text mining | PubMed |
| From screening to strategy: Clinical implications of COL4A3/COL4A4 variants found in reproductive genetic testing. | Eur J Hum Genet | 2026 | 41015616 | PubTator, text mining | PubMed |
| Treatment Approaches for Alport Syndrome. | J Am Soc Nephrol | 2026 | 40938675 | PubTator, text mining | PubMed |
| Response to "Autosomal Recessive Alport Syndrome Should Be Diagnosed in an m.3243A>G Carrier Only If a Pathogenic COL4A3 Variant Has Been Detected". | Intern Med | 2026 | 40903235 | PubTator, text mining | PubMed |
| Autosomal Recessive Alport Syndrome Should Be Diagnosed in an m.3243A>G Carrier Only If a Pathogenic COL4A3 Variant Has Been Detected. | Intern Med | 2026 | 40903234 | PubTator, text mining | PubMed |
| Combined Alport Syndrome Type 3A and Mitochondrial Disease Presenting with a Thin Base Membrane and Overt Albuminuria. | Intern Med | 2026 | 40603101 | PubTator, text mining | PubMed |
| Specialized gas-exchange endothelium of the zebrafish gill. | bioRxiv | 2025 | 41738028 | PubTator, text mining | PubMed |
| Disease-modifying effects of iron deficiency in mouse models of chronic renal failure. | Blood Red Cells Iron | 2025 | 41624374 | PubTator, text mining | PubMed |
| When Genes Reveal the Truth: Alport Syndrome Mimicking Steroid-Resistant Nephrotic Syndrome. | Pediatr Rep | 2025 | 41562995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=4